ID PGK1_HORSE Reviewed; 417 AA. AC P00559; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 02-SEP-2026, entry version 143. DE RecName: Full=Phosphoglycerate kinase 1; DE EC=2.7.11.1 {ECO:0000250|UniProtKB:P00558}; DE EC=2.7.2.3 {ECO:0000250|UniProtKB:P00558}; GN Name=PGK1; Synonyms=PGK; OS Equus caballus (Horse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus. OX NCBI_TaxID=9796; RN [1] RP PROTEIN SEQUENCE OF 2-417, AND SUBCELLULAR LOCATION. RC TISSUE=Muscle; RX PubMed=7287713; DOI=10.1016/s0021-9258(19)68618-7; RA Merrett M.; RT "Primary structure of 3-phosphoglycerate kinase from horse muscle. II. RT Amino acid sequence of cyanogen bromide peptides CB1-CB4 and CB6-CB14, RT sequence of methionine-containing regions, and complete sequence of the RT enzyme."; RL J. Biol. Chem. 256:10293-10305(1981). RN [2] RP X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS). RC TISSUE=Muscle; RX PubMed=450128; DOI=10.1038/279773a0; RA Banks R.D., Blake C.C.F., Evans P.R., Haser R., Rice D.W., Hardy G.W., RA Merrett M., Phillips A.W.; RT "Sequence, structure and activity of phosphoglycerate kinase: a possible RT hinge-bending enzyme."; RL Nature 279:773-777(1979). CC -!- FUNCTION: Catalyzes one of the two ATP producing reactions in the CC glycolytic pathway via the reversible conversion of 1,3- CC diphosphoglycerate to 3-phosphoglycerate. Both L- and D- forms of CC purine and pyrimidine nucleotides can be used as substrates, but the CC activity is much lower on pyrimidines. In addition to its role as a CC glycolytic enzyme, it seems that PGK-1 acts as a polymerase alpha CC cofactor protein (primer recognition protein). Acts as a protein kinase CC when localized to the mitochondrion where it phosphorylates pyruvate CC dehydrogenase kinase PDK1 to inhibit pyruvate dehydrogenase complex CC activity and suppress the formation of acetyl-coenzyme A from pyruvate, CC and consequently inhibit oxidative phosphorylation and promote CC glycolysis. May play a role in sperm motility. CC {ECO:0000250|UniProtKB:P00558}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(2R)-3-phosphoglycerate + ATP = (2R)-3-phospho-glyceroyl CC phosphate + ADP; Xref=Rhea:RHEA:14801, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:57604, ChEBI:CHEBI:58272, ChEBI:CHEBI:456216; EC=2.7.2.3; CC Evidence={ECO:0000250|UniProtKB:P00558}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14802; CC Evidence={ECO:0000250|UniProtKB:P00558}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:14803; CC Evidence={ECO:0000250|UniProtKB:P00558}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + CC H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CC Evidence={ECO:0000250|UniProtKB:P00558}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:P00558}; CC -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D- CC glyceraldehyde 3-phosphate: step 2/5. {ECO:0000250|UniProtKB:P00558}. CC -!- SUBUNIT: Monomer. Interacts with kinase MAPK1/ERK2; the interaction is CC direct, occurs under hypoxic conditions, and promotes its interaction CC with PIN1. Interacts with peptidyl-prolyl cis-trans isomerase PIN1; the CC interaction is direct, occurs under hypoxic conditions, and targets the CC protein to the mitochondrion by promoting interactions with the TOM CC complex. Interacts with mitochondrial circRNA mcPGK1 (via its 2nd stem- CC loop); the interaction is direct and targets the protein to the CC mitochondrion by promoting interactions with the TOM complex. Interacts CC with pyruvate dehydrogenase kinase PDK1; the interaction is direct, CC occurs under hypoxic conditions and leads to PDK1-mediated inhibition CC of pyruvate dehydrogenase complex activity. CC {ECO:0000250|UniProtKB:P00558}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:P00558}. Mitochondrion matrix CC {ECO:0000250|UniProtKB:P00558}. Note=Hypoxic conditions promote CC mitochondrial targeting. Targeted to the mitochondrion following CC phosphorylation by MAPK1/ERK2, cis-trans isomerization by PIN1, and CC binding to mitochondrial circRNA mcPGK1. CC {ECO:0000250|UniProtKB:P00558}. CC -!- PTM: Phosphorylated at Ser-203 by MAPK1/ERK2 under hypoxic conditions, CC which promotes its mitochondrial targeting. CC {ECO:0000250|UniProtKB:P00558}. CC -!- SIMILARITY: Belongs to the phosphoglycerate kinase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR PIR; A92292; KIHOG. DR PDB; 2PGK; X-ray; 3.00 A; A=-. DR AlphaFoldDB; P00559; -. DR SMR; P00559; -. DR FunCoup; P00559; 1001. DR STRING; 9796.ENSECAP00000012929; -. DR PaxDb; 9796-ENSECAP00000012929; -. DR PeptideAtlas; P00559; -. DR InParanoid; P00559; -. DR SABIO-RK; P00559; -. DR UniPathway; UPA00109; UER00185. DR Proteomes; UP000002281; Unplaced. DR GO; GO:0005829; C:cytosol; ISS:UniProtKB. DR GO; GO:0005759; C:mitochondrial matrix; ISS:UniProtKB. DR GO; GO:0043531; F:ADP binding; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IDA:UniProtKB. DR GO; GO:0004618; F:phosphoglycerate kinase activity; ISS:UniProtKB. DR GO; GO:0106310; F:protein serine kinase activity; ISS:UniProtKB. DR GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-EC. DR GO; GO:0006094; P:gluconeogenesis; IBA:GO_Central. DR GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-UniPathway. DR GO; GO:0016310; P:phosphorylation; NAS:UniProtKB. DR CDD; cd00318; Phosphoglycerate_kinase; 1. DR FunFam; 3.40.50.1260:FF:000019; Phosphoglycerate kinase 1; 1. DR FunFam; 3.40.50.1260:FF:000031; Phosphoglycerate kinase 1; 1. DR Gene3D; 3.40.50.1260; Phosphoglycerate kinase, N-terminal domain; 3. DR HAMAP; MF_00145; Phosphoglyc_kinase; 1. DR InterPro; IPR001576; Phosphoglycerate_kinase. DR InterPro; IPR015911; Phosphoglycerate_kinase_CS. DR InterPro; IPR015824; Phosphoglycerate_kinase_N. DR InterPro; IPR036043; Phosphoglycerate_kinase_sf. DR PANTHER; PTHR11406; PHOSPHOGLYCERATE KINASE; 1. DR PANTHER; PTHR11406:SF14; PHOSPHOGLYCERATE KINASE 1; 1. DR Pfam; PF00162; PGK; 1. DR PIRSF; PIRSF000724; Pgk; 1. DR PRINTS; PR00477; PHGLYCKINASE. DR SUPFAM; SSF53748; Phosphoglycerate kinase; 1. DR PROSITE; PS00111; PGLYCERATE_KINASE; 1. DR PDBsum; 2PGK; -. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; ATP-binding; Cytoplasm; KW Direct protein sequencing; Glycolysis; Hydroxylation; Kinase; Magnesium; KW Metal-binding; Mitochondrion; Nucleotide-binding; Phosphoprotein; KW Reference proteome; Transferase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P00558, FT ECO:0000269|PubMed:7287713" FT CHAIN 2..417 FT /note="Phosphoglycerate kinase 1" FT /id="PRO_0000145829" FT REGION 2..186 FT /note="Globular domain-1" FT REGION 38..43 FT /note="Mitochondrial targeting region exposed following FT cis-trans isomerization by PIN1 and recognized by the TOM FT complex for mitochondrial translocation of the protein" FT /evidence="ECO:0000250|UniProtKB:P00558" FT REGION 187..190 FT /note="Linker" FT REGION 191..417 FT /note="Globular domain-2" FT REGION 406..417 FT /note="Associated with globular domain 1" FT BINDING 23 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 24 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 25 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 26 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 38 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 39 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 62 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 63 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 65 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 66 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 122 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 123 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 170 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 171 FT /ligand="(2R)-3-phosphoglycerate" FT /ligand_id="ChEBI:CHEBI:58272" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 214 FT /ligand="ADP" FT /ligand_id="ChEBI:CHEBI:456216" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 214 FT /ligand="CDP" FT /ligand_id="ChEBI:CHEBI:58069" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 215 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 215 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 215 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 216 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 218 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 219 FT /ligand="CDP" FT /ligand_id="ChEBI:CHEBI:58069" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 219 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 220 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 220 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 238 FT /ligand="ADP" FT /ligand_id="ChEBI:CHEBI:456216" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 238 FT /ligand="CDP" FT /ligand_id="ChEBI:CHEBI:58069" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 239 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 239 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 313 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 313 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 338 FT /ligand="CDP" FT /ligand_id="ChEBI:CHEBI:58069" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 340 FT /ligand="CDP" FT /ligand_id="ChEBI:CHEBI:58069" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 343 FT /ligand="ADP" FT /ligand_id="ChEBI:CHEBI:456216" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 343 FT /ligand="CDP" FT /ligand_id="ChEBI:CHEBI:58069" FT /evidence="ECO:0000250|UniProtKB:P00558" FT BINDING 344 FT /ligand="AMP" FT /ligand_id="ChEBI:CHEBI:456215" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 344 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 375 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 375 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT BINDING 376 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:Q7SIB7" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 2 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 4 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 6 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P09411" FT MOD_RES 11 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 48 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 48 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P09411" FT MOD_RES 75 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 76 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P09411" FT MOD_RES 86 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 91 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P09411" FT MOD_RES 97 FT /note="N6-(2-hydroxyisobutyryl)lysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 97 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 131 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 131 FT /note="N6-malonyllysine; alternate" FT /evidence="ECO:0000250" FT MOD_RES 146 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 191 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P09411" FT MOD_RES 196 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 199 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 203 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 216 FT /note="N6-(2-hydroxyisobutyryl)lysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 220 FT /note="N6-(2-hydroxyisobutyryl)lysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 267 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 291 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 323 FT /note="N6-(2-hydroxyisobutyryl)lysine" FT /evidence="ECO:0000250|UniProtKB:P00558" FT MOD_RES 361 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P09411" SQ SEQUENCE 417 AA; 44603 MW; 5110E246AF96931A CRC64; MSLSNKLTLD KLNVKGKRVV MRVDFNVPMK NNQITNNQRI KAAVPSIKFC LDNGAKSVVL MSHLGRPDVG PMPDKYSLQP VAVELKSLLG KDVLFLKDCV GPEVEKACAD PAAGSVILLE NLRFHVEEEG KGKDASGNKV KAEPAKIETF RASLSKLGDV YVNDAFGTAH RAHSSMVGVN LPQKAGGFLM KKELNYFAKA LESPERPFLA ILGGAKVADK IQLINNMLDK VNEMIIGGGM AFTFLKVLNN MEIGTSLFDE EGAKIVKNLM SKAEKNGVKI TLPVDFVTAD KFDENAKTGQ ATVASGIPAG WMGLDCGTES SKKYAEAVAR AKQIVWNGPV GVFEWEAFAR GTKALMDEVV KATSRGCITI IGGGDTATCC AKWNTEDKVS HVSTGGGASL ELLEGKVLPG VDALSNV //